In the future, targeting PCSK9 might be a promising strategy for exploring the modulatory function of PCSK9 in the T-cell response and in some abnormal immune activities, such as autoimmune diseases or GVHD posttransplantation. Here, PCSK9 is linked to graft versus host disease.